Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
401k Retirement Calculator
Mortgage Calculator
Popular
Compound Interest Calculator
Dollar Cost Averaging
New
Student Loan Calculator
Auto Loan Calculator
Personal Finance
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
NTLA
Stock Latest News
The Fly
Cathie Wood’s ARK Investment bought 185K shares of Intellia Therapeutics today
13d ago
NTLA
Premium
The Fly
BlueAllele sues Intellia for patent infringement regarding ‘insertion templates’
13d ago
NTLA
Premium
Market News
3 Best Stocks to Buy Now, 6/28/2024, According to Top Analysts
24d ago
MU
UAL
Premium
Company Announcements
Intellia Therapeutics Welcomes New CFO, Announces Executive Transition
26d ago
8K
NTLA
Premium
Press Releases
Intellia Therapeutics Announces CFO Transition
26d ago
NTLA
Premium
The Fly
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
26d ago
FATE
NTLA
Premium
The Fly
Intellia reports proof-of-concept data for redosing CRISPR-based therapy
26d ago
NTLA
REGN
Premium
Press Releases
Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform
26d ago
NTLA
Premium
The Fly
Alnylam ATTR data positive for Intellia’s NTLA-2001, says Truist
28d ago
ALNY
NTLA
Premium
The Fly
Intellia Therapeutics to present data from patients redosed with NTLA-2001
1M ago
NTLA
Premium
Press Releases
Intellia Therapeutics to Present the First-Ever Clinical Data From Patients Redosed with an Investigational In Vivo CRISPR Gene Editing Therapy at the Peripheral Nerve Society Annual Meeting 2024
1M ago
NTLA
Premium
Company Announcements
Intellia Therapeutics Welcomes Brian Goff to Board of Directors
1M ago
8K
NTLA
Premium
Press Releases
Intellia Therapeutics Names Brian Goff to its Board of Directors
1M ago
NTLA
Premium
The Fly
Intellia Therapeutics appoints Brian Goff to board of directors
1M ago
AGIO
NTLA
Premium
The Fly
Cathie Wood’s ARK Investment bought 47K shares of Intellia Therapeutics today
1M ago
NTLA
Premium
The Fly
Cathie Wood’s ARK Investment bought 137K shares of Intellia Therapeutics today
2M ago
NTLA
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
AFMD
BPTH
Premium
The Fly
Cathie Wood’s ARK Investment bought 174K shares of Intellia Therapeutics today
2M ago
NTLA
Premium
The Fly
Intellia announces long-term data from ongoing Phase 1 study of NTLA-2002
2M ago
NTLA
Premium
Press Releases
Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
2M ago
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $29 from $31 at Citi
2M ago
NTLA
Premium
The Fly
Intellia Therapeutics reports Q1 EPS ($1.12), consensus ($1.38)
2M ago
NTLA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.